Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)

Name: Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)
License: Public Domain

Fondazione Ricerca Traslazionale

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic non small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230397
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.